Phillip D.

Phillip D. serves as a Board Observer at Abdera Therapeutics and Entact Bio. Previously, Phillip held various roles at Qiming Venture Partners USA, ND Capital, and Jasper Therapeutics. Phillip holds a Ph.D. in Bioengineering from Stanford University and a Bachelor's Degree in Mathematics, Cognitive Science, and Biomedical Engineering from the University of Virginia.